Intellia Therapeutics Inc... (NTLA)
NASDAQ: NTLA
· Real-Time Price · USD
11.07
0.08 (0.73%)
At close: Aug 18, 2025, 1:09 PM
Intellia Therapeutics Revenue
Intellia Therapeutics reported an annual revenue of $57.88M, reflecting a 59.55% growth. For the quarter ending June 30, 2025, Intellia Therapeutics generated $14.24M in revenue.
Revenue (ttm)
57.88M
Revenue Growth
59.55%
Price / Sales Ratio
19.91
Revenue / Employee
143.62K
Employees
403
Market Cap
1.19B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 57.88M | +59.55% |
| Dec 31, 2023 | 36.27M | -30.40% |
| Dec 31, 2022 | 52.12M | +57.69% |
| Dec 31, 2021 | 33.05M | -43.01% |
| Dec 31, 2020 | 57.99M | +34.55% |
| Dec 31, 2019 | 43.1M | +41.63% |
| Dec 31, 2018 | 30.43M | +16.53% |
| Dec 31, 2017 | 26.12M | +58.49% |
| Dec 31, 2016 | 16.48M | +172.65% |
| Dec 31, 2015 | 6.04M | +Infinity% |
| Dec 31, 2014 | 0 | n/a |